Cytosorbents (CTSO) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Cytosorbents (CTSO) over the last 15 years, with Q3 2025 value amounting to -$645000.0.
- Cytosorbents' Interest & Investment Income fell 969.39% to -$645000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.5 million, marking a year-over-year decrease of 20115.86%. This contributed to the annual value of -$1.4 million for FY2024, which is 78611.26% down from last year.
- As of Q3 2025, Cytosorbents' Interest & Investment Income stood at -$645000.0, which was down 969.39% from -$616000.0 recorded in Q2 2025.
- In the past 5 years, Cytosorbents' Interest & Investment Income registered a high of $53748.0 during Q4 2022, and its lowest value of -$645000.0 during Q3 2025.
- Its 5-year average for Interest & Investment Income is -$171693.1, with a median of -$10124.0 in 2021.
- Per our database at Business Quant, Cytosorbents' Interest & Investment Income soared by 33718.89% in 2022 and then crashed by 899565.61% in 2025.
- Quarter analysis of 5 years shows Cytosorbents' Interest & Investment Income stood at $12294.0 in 2021, then surged by 337.19% to $53748.0 in 2022, then crashed by 197.17% to -$52229.0 in 2023, then tumbled by 1094.91% to -$624092.0 in 2024, then fell by 3.35% to -$645000.0 in 2025.
- Its last three reported values are -$645000.0 in Q3 2025, -$616000.0 for Q2 2025, and -$605134.0 during Q1 2025.